Interventions that moderate a need for ‘sameness’ may prevent anxiety traits.

Interim results from the previously paused trial suggest that doses of the experimental gene therapy drug GTX-102 are well tolerated in children with the autism-linked condition.

Most autistic children in the Netherlands have used some sort of treatment, but the number, type and timing varies depending on considerations unrelated to their condition.

When the federal public health emergency expires, so too could temporary insurance coverage of applied behavior analysis conducted remotely. A proposed rule could block those changes, however, at least for people with public insurance.

A handful of scientists are committed to advancing research on the autism-related genetic conditions their own children have.

After the vasopressin antagonist balovaptan flopped in a late-stage clinical trial, Suma Jacob and her colleagues took stock of all the factors that might have complicated the results.

Genetic factors could help explain why the ‘social hormone’ failed to benefit autistic people in a phase 3 clinical trial last year.

Doctors can prescribe it, but evidence that ketamine eases autism traits is still preliminary.

Swiss biotech Stalicla hopes to bring precision medicine to autism. Experts praise efforts to identify autism subgroups, but evidence to support the company’s claims has yet to be seen.

The approach, tested in mice, selectively boosts the expression of the autism-linked gene SCN1A in a subgroup of inhibitory cells.